LDN-27219 CANCER TREATMENT RESEARCH - AN OVERVIEW

LDN-27219 cancer treatment research - An Overview

Consensus sequence for tTG crosslinking substrates. Alignment of all glutamine-donor crosslinking substrates described during the Transdab databases demonstrates that besides glutamine (Q at situation 0), there is small to no favoritism for various residues at up to 5 positions just before or after the glutamine residue to become crosslinked. Deter

read more